Bridge Venture Partners VI L. P. North serves as Executive at Lyra Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Bridge Venture Partners VI L. P. North has executed 3 insider transactions totaling $4.4M, demonstrating a bullish approach to their equity position. Their most recent transaction on May 31, 2023 involved purchasing 197,946 shares valued at $481.0K.
Bridge Venture Partners VI L. P. North currently holds 1,107,370 shares of Lyra Therapeutics, Inc. (LYRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bridge Venture Partners VI L. P. North has been a net buyer of LYRA stock. They have purchased $4.4M and sold $0 worth of shares.
Bridge Venture Partners VI L. P. North's most recent insider trade was on May 31, 2023, when they purchased 197,946 shares at $2.43 per share.
Get notified when new Form 4 filings are submitted
| $2.43 |
| Discretionary |
| May 31, 2023 | LYRA | $981.4K | Purchase | 403,858 | $2.43 | Discretionary |